Brief: Fennec Pharmaceuticals Reports Q3 Loss Of $0.31 Per Share

Fennec Pharmaceuticals

11/11/2022 12:12

Nov 11 (Reuters) - Fennec Pharmaceuticals Inc  FENC.O :
    * FENNEC PHARMACEUTICALS ANNOUNCES THIRD QUARTER 2022
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
    * QTRLY LOSS PER SHARE $0.31
    * CASH AND CASH EQUIVALENTS WERE $29.8 MILLION AT SEPTEMBER
30,
2022
    * Q3 EARNINGS PER SHARE VIEW $-0.18 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX6xmRMs 
Further company coverage:  FENC.O 
 ((Reuters.Briefs@thomsonreuters.com;))